Table of Contents
Obesity-Diabetes-Reducing Injection: New Drug is 15 Percent Effective in Weight Loss, Reduces the Risk of type-2 Diabetes by 61 Percent
Ozempic, a widely recognized medication for diabetes and weight management, has shown promising results in recent studies. The number of people suffering from diabetes is increasing worldwide. According to the International Diabetes Federation (IDF), 537 million people between the ages of 20-79 are living with this disease. However, scientists have recently conducted new research to protect people against this problem. According to this research, an injection used for weight loss reduces the risk of type-2 diabetes by 61%.
The drug is called Semaglutide. The injection, Semaglutide, has been brought to the market by the brands Wegovy and Ozempic. It has recently been approved by the Food and Drug Association (FDA) of America and the National Institute for Health and Care Excellence (NICE) of England. This is a weight loss drug, meaning that its use can control obesity.
Semaglutide is the Most Effective Drug for Weight Loss
People often resort to surgery to get rid of obesity in the long term, but the lead researcher of this study, Dr. W. Timothy Garvey, says that Semaglutide is the most effective drug to control obesity so far. This injection can be relied on after bariatric surgery. The results of clinical trials showed that it reduced weight by an average of more than 15%. By losing this much weight, many types of health-related problems can also be avoided.
Know What Is Ozempic
It is a medicine for adults who suffer from type 2 diabetes, which can improve blood sugar with diet and exercise. While Ozempic is not for weight loss, it can help people lose some weight. Ozempic is a drug injected once a week, but experts say it is not a miracle drug.
About this, Forbes said that the active compound in Ozempic, semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist. It works by activating GLP-1 receptors throughout the body and increasing the effects of the naturally occurring hormone GLP-1. Semaglutide affects weight by affecting appetite centers in the brain and slowing the rate of stomach emptying, gastroenterologist Christopher McGowan told the outlet.
Obesity Increases the Risk of Diabetes
Dr. Garvey said that obesity increases the risk of type-2 diabetes by 6 times, so his team conducted two trials to understand the connection between Semaglutide and diabetes. In the first trial, candidates who were injected with Semaglutide got amazing results in 68 weeks, their risk of diabetes decreased by 61 percent for 10 years. Along with this, 17 percent weight was also reduced.
In the second trial, candidates were given Semaglutide for 20 weeks. After that, some people were put on a placebo treatment and some were given Semaglutide. A placebo is not a drug, but it is a treatment that doctors use to see how a drug affects a patient psychologically.
Continuous use of Semaglutide is Essential.
In another trial, scientists found that people who continued taking Semaglutide consistently had a 7.7 percent reduction in their risk of developing diabetes per week, while those treated with placebo had a 15.4 percent increase in their risk of the disease. This suggests that continuous use of Semaglutide is effective.
Read More: Effective Diet Tips to Control Diabetes, High Blood Pressure, and Low Blood Pressure Naturally
Conclusion
The findings of this study have revealed that Semaglutide (Ozempic) injection is very effective in reducing the risk of obesity and type-2 diabetes. The drug not only reduces weight by an average of 15%, but also reduces the risk of diabetes by 61% over 10 years. According to researchers, obesity increases the risk of type-2 diabetes by 6 times, in such a situation, regular use of Semaglutide can prove to help deal with this problem. However, continuous use of the drug is necessary for its permanent results. This drug can also help reduce other health problems related to obesity.